Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacteol Fort in NAFLD
NCT06074094Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Lactobacillus LB in non-alcoholic fatty liver disease (NAFLD), sponsored by Ain Shams University. Started Sep 2021; status: completed.
02
Drugs
Lactobacillus LB
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT06074094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06074094.